Saturday 17 October 2026
Export SCL’s income statement to Excel — free account
Stepan Company
SCL Basic Materials Specialty Chemicals
Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024. In the quarter to June 2026, revenue grew 15.0%, EPS grew 100.0%, free cash flow fell 4.42% and total debt fell 1.62%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
62.03
0.16
+0.26%
Follow SCL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
3.67% | 3.89% | (1.19%) | (0.22%) | |
Piotroski F-Score |
5 | 5 | 4 | 4 | |
| 1.87% | 2.01% | (0.60%) | (0.11%) | ||
ROIC |
2.65% | 2.82% | 0.02% | 0.71% | |
Return on Tangible Assets |
3.17% | 3.32% | (1.07%) | (0.21%) | |
Average Days of Receivables |
69.10 | 60.72 | 67.55 | 73.87 | |
Free Cash Flow per Share |
1.40 | 2.27 | 2.79 | 2.76 | |
Free Cash Flow |
32.08 | 51.96 | 63.81 | 63.17 | |
Capital Expenditures |
(124.10) | (95.93) | (94.07) | (91.87) | |
| Other line items | |||||
Cash ROIC |
1.59% | 2.59% | 3.21% | 3.20% | |
Accounts Receivable Turnover |
5.29 | 6.01 | 5.39 | 5.21 | |
Accounts Payable Turnover |
7.43 | 7.92 | 7.14 | 7.11 | |
Inventory Turnover |
6.53 | 7.02 | 6.97 | 6.56 | |
Average Days of Payables |
52.06 | 46.32 | 50.04 | 54.72 | |
Days of Inventory on Hand |
58.34 | 52.89 | 50.62 | 55.20 | |
Tax Rate |
(0.21) | (0.22) | (0.26) | 4.46 | |
Research and Development Expense of Revenue |
2.49% | 2.54% | 2.54% | 2.55% | |
Selling, General and Administrative Expense of Revenue |
6.16% | 6.08% | 6.11% | 5.94% | |
Share Based Compensation of Revenue |
0.23% | 0.26% | 0.26% | 0.27% | |
Interest Coverage |
3.56 | 3.55 | 0.03 | 0.86 | |
Operating CF/Net income |
3.45 | 3.15 | (11.10) | (58.46) | |
Depreciation/Fixed assets |
0.10 | 0.10 | 0.11 | 0.11 | |
Capex/Depreciation |
(1.02) | (0.76) | (0.73) | (0.71) | |
Revenue per Share |
100.71 | 101.96 | 102.38 | 106.25 | |
Operating CF per Share |
6.83 | 6.47 | 6.90 | 6.77 | |
Capex per Share |
(5.43) | (4.19) | (4.11) | (4.01) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.04 |
Columns are period end dates